RESMED INC (RMD) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:RMD - US7611521078 - Common Stock
244.785 USD
+0.34 (+0.14%)
ChartMill assigns a Buy % Consensus number of 76% to RMD. The Buy consensus is the weighted average rating of the current analysts ratings.
RMD was analyzed by 25 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about RMD.
In the previous month the buy percentage consensus was at a similar level.
RMD was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-18 | Stifel | Maintains | Hold -> Hold |
| 2025-12-16 | Baird | Downgrade | Outperform -> Neutral |
| 2025-11-03 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-31 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-31 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-13 | Wells Fargo | Initiate | Equal-Weight |
| 2025-09-18 | Citigroup | Initiate | Buy |
| 2025-08-01 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-08-01 | UBS | Maintains | Buy -> Buy |
| 2025-08-01 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-08-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-01 | Stifel | Maintains | Hold -> Hold |
| 2025-08-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-16 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-16 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-04-24 | UBS | Maintains | Buy -> Buy |
| 2025-04-24 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-24 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-04-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-24 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-21 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-03-05 | Stifel | Maintains | Hold -> Hold |
| 2025-03-05 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-01-31 | Needham | Reiterate | Hold -> Hold |
| 2025-01-31 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-01-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-31 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-10 | Piper Sandler | Initiate | Neutral |
RESMED INC / RMD FAQ
What is the consensus rating for RESMED INC (RMD) stock?
The consensus rating for RESMED INC (RMD) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for RMD stock?
The number of analysts covering RESMED INC (RMD) is 25.